Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Myriad Genetics Receives Favorable Ruling on Gene Patentability

August 22, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Myriad Genetics reported that a US federal appeals court has ruled that the company's composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible material under federal patent law. The court, however, denied the company's effort to patent methods of "comparing" or "analyzing" DNA sequences.

Eli Lilly Receives $1.3 Billion Following Bristol-Myers Squibb's Acquisition of Amylin Pharmaceuticals

August 22, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly has received $1.3 billion for payment of financial obligations from Amylin Pharmaceuticals following Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals earlier this month.

Grey-Market Distributor Convicted of Defrauding FDA

August 20, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

South Carolina-based Altec Medical pleaded guilty to one count of conspiring to defraud FDA and to commit federal offenses in connection with a drug-diversion scheme that lasted from 2007 to 2009.

AstraZeneca and Bristol-Myers Squibb Extend Diabetes Alliance

August 13, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

AstraZeneca has paid approximately $3.2 billion to extend its diabetes alliance with Bristol-Myers Squibb (BMS), following BMS's recently completed acquisition of Amylin Pharmaceuticals.

Elan to Spin Off Discovery Sciences

August 13, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Elan Corporation announced plans to spin off its discovery unit and Neotope Biosciences division to create an independent entity focused on R&D.

Pfizer Settles with DOJ and SEC on Improper Conduct in Select Emerging Markets

August 7, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

An internal investigation and voluntary disclosure by Pfizer led to a settlement with the US Department of Justice and Securities and Exchange Commission.

Carbon Measurement Methods for Cleaning Validation (Peer Reviewed)

August 2, 2012

Pharmaceutical Technology

The authors compare direct combustion with rinse and swab sampling methods.

Measuring Growth in Big Pharma's Manufacturing Investment

August 2, 2012

Pharmaceutical Technology

Pharmaceutical Technology's annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.

Pharmaceutical-Based Cargo Security and Theft Prevention

August 2, 2012

Pharmaceutical Technology

The author discusses strategies for preventing cargo theft.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here